<!doctype html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta name="viewport" content="width=device-width, initial-scale=1"/>
<title>FGR + Absent End-Diastolic Flow (AEDV) at 35 Weeks</title>
<style>
  :root{
    --bg:#07111c;
    --panel:#0b1c2c;
    --fg:#f4f7fb;
    --muted:#b7c4d6;
    --accent:#35d0ff;
    --accent2:#ff4d6d;
    --ok:#2ee6a6;
    --warn:#ffd166;
    --line:#16324a;
  }
  html,body{height:100%; margin:0; font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Arial, "Noto Sans", "Helvetica Neue", sans-serif; background:var(--bg); color:var(--fg);}
  .deck{height:100%; display:flex; flex-direction:column;}
  .topbar{
    display:flex; align-items:center; justify-content:space-between;
    padding:10px 16px; border-bottom:1px solid var(--line); background:rgba(11,28,44,0.6); backdrop-filter: blur(6px);
  }
  .title{font-weight:700; letter-spacing:.2px; font-size:14px; color:var(--muted);}
  .meta{display:flex; gap:10px; align-items:center;}
  .pill{border:1px solid var(--line); color:var(--muted); padding:4px 10px; border-radius:999px; font-size:12px;}
  .pill b{color:var(--fg);}
  .progress{height:6px; background:#06101a; border-top:1px solid var(--line); border-bottom:1px solid var(--line);}
  .bar{height:100%; width:0%; background:linear-gradient(90deg,var(--accent),var(--ok));}
  .slides{flex:1; position:relative; overflow:hidden;}
  section.slide{
    position:absolute; inset:0; padding:42px 56px;
    display:grid; grid-template-rows:auto 1fr auto; gap:22px;
    opacity:0; transform: translateX(18px); transition: opacity .25s ease, transform .25s ease;
    pointer-events:none;
  }
  section.slide.active{opacity:1; transform: translateX(0); pointer-events:auto;}
  .h1{font-size:44px; line-height:1.05; font-weight:800; letter-spacing:.2px;}
  .h2{font-size:28px; line-height:1.15; font-weight:800; color:var(--fg);}
  .sub{color:var(--muted); font-size:18px; line-height:1.35; max-width:1000px;}
  .grid{display:grid; gap:18px;}
  .cols-2{grid-template-columns: 1.15fr .85fr;}
  .cols-3{grid-template-columns: 1fr 1fr 1fr;}
  .card{
    background:linear-gradient(180deg, rgba(11,28,44,.92), rgba(9,22,35,.92));
    border:1px solid var(--line); border-radius:18px; padding:18px 18px;
    box-shadow: 0 10px 30px rgba(0,0,0,.25);
  }
  .k{font-size:13px; color:var(--muted); text-transform:uppercase; letter-spacing:1.2px;}
  ul{margin:10px 0 0 0; padding-left:18px;}
  li{margin:8px 0; font-size:20px; line-height:1.25;}
  .big{font-size:24px; line-height:1.2;}
  .em{color:var(--accent); font-weight:800;}
  .danger{color:var(--accent2); font-weight:800;}
  .ok{color:var(--ok); font-weight:800;}
  .warn{color:var(--warn); font-weight:800;}
  .footer{display:flex; justify-content:space-between; align-items:center; color:var(--muted); font-size:13px;}
  .keys{opacity:.9}
  .kbd{border:1px solid var(--line); border-bottom-width:2px; padding:2px 8px; border-radius:8px; color:var(--muted); font-size:12px;}
  .tagrow{display:flex; gap:10px; flex-wrap:wrap; margin-top:10px;}
  .tag{border:1px solid var(--line); padding:6px 10px; border-radius:12px; font-size:14px; color:var(--muted);}
  .tag b{color:var(--fg);}
  /* Visuals */
  .svgwrap{display:flex; align-items:center; justify-content:center; height:100%;}
  .callout{
    border-left:6px solid var(--accent2);
    background:rgba(255,77,109,.08);
    padding:14px 16px; border-radius:14px; border:1px solid rgba(255,77,109,.28);
  }
  .callout .h{font-weight:800; color:var(--fg); font-size:16px; margin-bottom:6px;}
  .callout .t{color:var(--muted); font-size:16px; line-height:1.3;}
  .small{font-size:16px; color:var(--muted);}
  .note{font-size:14px; color:var(--muted);}
  .divider{height:1px; background:var(--line); margin:10px 0;}
  /* Print-friendly */
  @media print{
    .topbar,.progress{display:none;}
    section.slide{position:relative; opacity:1; transform:none; page-break-after:always; pointer-events:auto;}
    body{background:white; color:black;}
    .card{box-shadow:none;}
  }
</style>
</head>
<body>
<div class="deck">
  <div class="topbar">
    <div class="title">Fetal Growth Restriction + Absent End-Diastolic Flow (Umbilical Artery) at <b>35 weeks</b></div>
    <div class="meta">
      <div class="pill"><b id="idx">1</b> / <span id="tot">12</span></div>
      <div class="pill">One point / slide</div>
      <div class="pill keys"><span class="kbd">←</span> <span class="kbd">→</span> <span class="kbd">Space</span> <span class="kbd">Home</span> <span class="kbd">End</span></div>
    </div>
  </div>
  <div class="progress"><div class="bar" id="bar"></div></div>

  <div class="slides" id="slides">

    <!-- Slide 1 -->
    <section class="slide active">
      <div>
        <div class="h1">FGR + <span class="danger">AEDV</span> at 35 weeks</div>
        <div class="sub">Clinical approach to late-preterm FGR with absent umbilical artery end-diastolic velocity (placental insufficiency phenotype).</div>
        <div class="tagrow">
          <div class="tag"><b>Audience:</b> OB residents / fellows / MFM</div>
          <div class="tag"><b>Scope:</b> screening → diagnosis → management</div>
        </div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Teaching point</div>
          <div class="big" style="margin-top:10px;">
            At <span class="em">35 weeks</span>, persistent <span class="danger">AEDV</span> usually crosses the threshold for <span class="em">delivery planning now</span>, not prolonged expectant management.
          </div>
        </div>
        <div class="card">
          <div class="k">Why it matters</div>
          <ul>
            <li>High placental resistance → fetal hypoxemia risk</li>
            <li>Stillbirth risk rises as Dopplers worsen</li>
            <li>Labor tolerance may be limited</li>
          </ul>
        </div>
      </div>
      <div class="footer">
        <span class="note">High-contrast, minimal text: designed for oral teaching.</span>
        <span class="note">Use local protocols + individualized judgment.</span>
      </div>
    </section>

    <!-- Slide 2 -->
    <section class="slide">
      <div>
        <div class="h2">Define the problem</div>
        <div class="sub">Confirm you are managing <span class="em">FGR</span> (not constitutionally small) <span class="em">plus</span> pathologic placental Doppler.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Diagnosis frame</div>
          <ul>
            <li>EFW or AC <span class="em">&lt;10th percentile</span> (severe: <span class="em">&lt;3rd</span>)</li>
            <li>Umbilical artery: <span class="danger">absent end-diastolic flow</span></li>
            <li>Exclude anomalies / infection when indicated</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Common pitfalls</div>
          <ul>
            <li>Dating error → mislabeling FGR</li>
            <li>Single Doppler sample → repeat for persistence</li>
            <li>Mixing “SGA” with “FGR” in counseling</li>
          </ul>
        </div>
      </div>
      <div class="footer">
        <span>Point: get the phenotype right before acting.</span>
        <span class="note">AEDV = placental insufficiency until proven otherwise.</span>
      </div>
    </section>

    <!-- Slide 3 -->
    <section class="slide">
      <div>
        <div class="h2">Pathophysiology</div>
        <div class="sub">AEDV reflects <span class="em">marked</span> placental vascular resistance and reduced fetoplacental perfusion.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Concept chain</div>
          <ul>
            <li>Abnormal placentation → high resistance villous bed</li>
            <li>↓ Diastolic flow → ↓ oxygen delivery reserve</li>
            <li>Progression risk: AEDV → REDV → acidemia</li>
          </ul>
          <div class="divider"></div>
          <div class="callout">
            <div class="h">Clinical meaning</div>
            <div class="t">Not “small only.” It is a hemodynamic signal of compromised placental function.</div>
          </div>
        </div>
        <div class="card">
          <div class="k">Umbilical artery waveform (schematic)</div>
          <div class="svgwrap">
            <svg width="460" height="240" viewBox="0 0 460 240" role="img" aria-label="Umbilical artery Doppler schematic showing absent end-diastolic flow">
              <rect x="0" y="0" width="460" height="240" rx="16" fill="rgba(6,16,26,.55)" stroke="#16324a"/>
              <line x1="40" y1="170" x2="420" y2="170" stroke="#16324a" stroke-width="2"/>
              <text x="44" y="196" fill="#b7c4d6" font-size="12">Baseline</text>

              <!-- Pulses with absent diastolic -->
              <path d="M60 170
                       C75 90, 95 90, 110 170
                       L140 170
                       C155 95, 175 95, 190 170
                       L220 170
                       C235 105, 255 105, 270 170
                       L300 170
                       C315 95, 335 95, 350 170
                       L380 170" fill="none" stroke="#35d0ff" stroke-width="4"/>

              <text x="44" y="28" fill="#f4f7fb" font-size="16" font-weight="700">AEDV</text>
              <text x="44" y="50" fill="#b7c4d6" font-size="12">Peak systolic present</text>
              <text x="44" y="66" fill="#b7c4d6" font-size="12">Diastolic flow = 0</text>

              <rect x="292" y="28" width="142" height="62" rx="12" fill="rgba(255,77,109,.10)" stroke="rgba(255,77,109,.35)"/>
              <text x="305" y="52" fill="#ff4d6d" font-size="12" font-weight="800">Higher risk phenotype</text>
              <text x="305" y="70" fill="#b7c4d6" font-size="11">vs elevated PI alone</text>
            </svg>
          </div>
        </div>
      </div>
      <div class="footer">
        <span>Point: AEDV is a severity marker for placental insufficiency.</span>
        <span class="note">Progression can be rapid or stepwise.</span>
      </div>
    </section>

    <!-- Slide 4 -->
    <section class="slide">
      <div>
        <div class="h2">Risk factors to surface (fast)</div>
        <div class="sub">Risk stratification helps anticipate maternal disease and neonatal course.</div>
      </div>
      <div class="grid cols-3">
        <div class="card">
          <div class="k">Maternal</div>
          <ul>
            <li>Chronic HTN / preeclampsia</li>
            <li>Renal / autoimmune disease</li>
            <li>Smoking, substance exposure</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Placental / pregnancy</div>
          <ul>
            <li>Abnormal placentation</li>
            <li>Multiple gestation</li>
            <li>Prior FGR / stillbirth</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Fetal</div>
          <ul>
            <li>Aneuploidy / anomalies</li>
            <li>Infection (when suspected)</li>
            <li>Severe oligohydramnios</li>
          </ul>
        </div>
      </div>
      <div class="footer">
        <span>Point: AEDV is often a placental disease signal; look for maternal hypertensive disease.</span>
        <span class="note">Investigations should be indication-driven.</span>
      </div>
    </section>

    <!-- Slide 5 -->
    <section class="slide">
      <div>
        <div class="h2">Immediate confirmation at 35 weeks</div>
        <div class="sub">Before action: confirm persistence, fetal status, and competing indications for expedited delivery.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Do now</div>
          <ul>
            <li>Repeat UA Doppler (confirm <span class="danger">persistent</span> AEDV)</li>
            <li>BPP or NST + AFI/SDP</li>
            <li>Maternal evaluation: BP, symptoms, labs if indicated</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Interpretation</div>
          <ul>
            <li><span class="danger">Nonreassuring testing</span> → deliver urgently</li>
            <li>Reassuring testing still ≠ “safe for weeks”</li>
            <li>Document dating + growth trajectory</li>
          </ul>
          <div class="callout" style="margin-top:12px;">
            <div class="h">Uncertainty flag</div>
            <div class="t">Intermittent vs persistent AEDV may differ in risk; manage conservatively when uncertain.</div>
          </div>
        </div>
      </div>
      <div class="footer">
        <span>Point: confirm phenotype, then move to delivery planning.</span>
        <span class="note">Avoid serial delays waiting for “more data.”</span>
      </div>
    </section>

    <!-- Slide 6 -->
    <section class="slide">
      <div>
        <div class="h2">Delivery timing: where 35 weeks fits</div>
        <div class="sub">Evidence-based guidance generally recommends <span class="em">earlier</span> delivery for AEDV than 35 weeks.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Guideline anchor (concept)</div>
          <ul>
            <li>AEDV typically triggers delivery around <span class="em">33–34 weeks</span></li>
            <li>REDV earlier (often <span class="em">30–32 weeks</span>)</li>
            <li>At 35 weeks: balance shifts toward <span class="em">delivery now</span></li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Risk tradeoff at 35 weeks</div>
          <ul>
            <li>Placental failure risk persists (stillbirth/acidemia)</li>
            <li>Late-preterm neonatal risks are real but lower than earlier GA</li>
            <li>Goal: minimize exposure time to compromised placenta</li>
          </ul>
        </div>
      </div>
      <div class="footer">
        <span>Point: AEDV at 35 weeks is “past threshold” for expectant management.</span>
        <span class="note">Source concepts: SMFM Consult #52; ACOG FGR PB.</span>
      </div>
    </section>

    <!-- Slide 7 -->
    <section class="slide">
      <div>
        <div class="h2">Antenatal meds (late preterm)</div>
        <div class="sub">Use interventions that improve neonatal outcomes <span class="em">without</span> delaying indicated delivery.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Consider</div>
          <ul>
            <li><span class="em">Betamethasone</span> if delivery likely within 7 days and no prior course</li>
            <li>Group B strep prophylaxis per status</li>
            <li>NICU consult; plan thermoregulation/glucose support</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Not routine at 35 weeks</div>
          <ul>
            <li><span class="warn">Magnesium neuroprotection</span> (typically &lt;32 weeks)</li>
            <li>Tocolysis to “finish steroids” in a compromised fetus</li>
            <li>Prolonged observation if testing deteriorates</li>
          </ul>
          <div class="callout" style="margin-top:12px; border-left-color: var(--warn); background: rgba(255,209,102,.08); border-color: rgba(255,209,102,.28);">
            <div class="h">Principle</div>
            <div class="t">Steroids may be helpful, but fetal status dictates urgency.</div>
          </div>
        </div>
      </div>
      <div class="footer">
        <span>Point: optimize neonatal transition, don’t justify unsafe delay.</span>
        <span class="note">Align with institutional late-preterm steroid criteria.</span>
      </div>
    </section>

    <!-- Slide 8 -->
    <section class="slide">
      <div>
        <div class="h2">Mode of delivery: decision framework</div>
        <div class="sub">AEDV increases risk of intrapartum compromise; route should be individualized.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Favors induction</div>
          <ul>
            <li>Reassuring testing; no additional red flags</li>
            <li>Favorable cervix; vertex; reasonable EFW</li>
            <li>Capacity for <span class="em">continuous EFM</span> + rapid operative delivery</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Favors cesarean</div>
          <ul>
            <li>Nonreassuring NST/BPP, recurrent decelerations</li>
            <li>Severe growth restriction + poor reserve</li>
            <li>Unfavorable cervix with high likelihood of prolonged labor</li>
          </ul>
          <div class="callout" style="margin-top:12px;">
            <div class="h">Communicate clearly</div>
            <div class="t">“Higher chance of urgent cesarean during labor” should be explicit in counseling.</div>
          </div>
        </div>
      </div>
      <div class="footer">
        <span>Point: AEDV is not an automatic cesarean, but it lowers labor tolerance.</span>
        <span class="note">Document shared decision-making.</span>
      </div>
    </section>

    <!-- Slide 9 -->
    <section class="slide">
      <div>
        <div class="h2">If delivery is not immediate (rare)</div>
        <div class="sub">Only if testing is reassuring and a brief, protocolized window is clinically justified.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Minimum surveillance</div>
          <ul>
            <li>Inpatient or very close monitoring</li>
            <li>Frequent NST/CTG; repeat UA Doppler</li>
            <li>Low threshold to deliver with any deterioration</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Triggers to deliver now</div>
          <ul>
            <li><span class="danger">Reversed</span> UA flow or worsening Dopplers</li>
            <li>Abnormal CTG / BPP, oligohydramnios worsening</li>
            <li>Maternal indication (preeclampsia, severe HTN)</li>
          </ul>
          <div class="callout" style="margin-top:12px;">
            <div class="h">Reality check</div>
            <div class="t">At 35 weeks with persistent AEDV, extended expectant management is usually not favored.</div>
          </div>
        </div>
      </div>
      <div class="footer">
        <span>Point: surveillance cannot “treat” placental insufficiency.</span>
        <span class="note">Use standardized pathways to reduce variability.</span>
      </div>
    </section>

    <!-- Slide 10 -->
    <section class="slide">
      <div>
        <div class="h2">Intrapartum priorities</div>
        <div class="sub">Assume limited reserve; plan for rapid response to evolving fetal acidemia.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Monitoring</div>
          <ul>
            <li>Continuous EFM; interpret conservatively</li>
            <li>Early attention to recurrent variable/late decels</li>
            <li>Prompt escalation: intrauterine resuscitation + decision</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Operational readiness</div>
          <ul>
            <li>OR availability; anesthesia aware</li>
            <li>Neonatal team present at delivery</li>
            <li>Avoid prolonged second stage if tracing deteriorates</li>
          </ul>
          <div class="callout" style="margin-top:12px; border-left-color: var(--accent); background: rgba(53,208,255,.08); border-color: rgba(53,208,255,.25);">
            <div class="h">Key phrase</div>
            <div class="t">“Low threshold for operative delivery.”</div>
          </div>
        </div>
      </div>
      <div class="footer">
        <span>Point: the safest plan is the one you can execute quickly.</span>
        <span class="note">Debrief the team before starting induction.</span>
      </div>
    </section>

    <!-- Slide 11 -->
    <section class="slide">
      <div>
        <div class="h2">Neonatal implications at 35 weeks</div>
        <div class="sub">Counsel on both prematurity and growth restriction effects.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Expected issues</div>
          <ul>
            <li>Hypoglycemia risk; feeding support</li>
            <li>Thermoregulation challenges</li>
            <li>Respiratory morbidity possible (late preterm)</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Delivery room plan</div>
          <ul>
            <li>NICU/SCN presence; glucose protocol</li>
            <li>Delayed cord clamping if stable and feasible</li>
            <li>Placenta to pathology (often high yield)</li>
          </ul>
        </div>
      </div>
      <div class="footer">
        <span>Point: anticipatory guidance reduces surprise and improves coordination.</span>
        <span class="note">Align with institutional late-preterm care bundles.</span>
      </div>
    </section>

    <!-- Slide 12 -->
    <section class="slide">
      <div>
        <div class="h2">One-slide algorithm (take-home)</div>
        <div class="sub">For <span class="em">35 weeks</span> with <span class="danger">persistent AEDV</span> in FGR.</div>
      </div>
      <div class="grid cols-2">
        <div class="card">
          <div class="k">Algorithm</div>
          <ul>
            <li>Confirm dating + persistent AEDV</li>
            <li>Assess fetal status (NST/BPP + fluid)</li>
            <li><span class="danger">Plan delivery now</span> (route individualized)</li>
            <li>Consider late-preterm steroids if feasible without unsafe delay</li>
          </ul>
        </div>
        <div class="card">
          <div class="k">Evidence anchors</div>
          <ul>
            <li>SMFM Consult Series #52: FGR + Doppler-based timing</li>
            <li>ACOG Practice Bulletin: FGR evaluation and management</li>
            <li>Key idea: AEDV indicates high-risk placental insufficiency</li>
          </ul>
          <div class="small" style="margin-top:10px;">
            This deck is educational; apply local protocols and patient-specific factors.
          </div>
        </div>
      </div>
      <div class="footer">
        <span>Point: at 35 weeks, AEDV usually means “deliver.”</span>
        <span class="note">SMFM/ACOG-aligned principles.</span>
      </div>
    </section>

  </div>
</div>

<script>
(function(){
  const slides = Array.from(document.querySelectorAll('section.slide'));
  const tot = slides.length;
  const idxEl = document.getElementById('idx');
  const totEl = document.getElementById('tot');
  const bar = document.getElementById('bar');
  totEl.textContent = tot;

  let i = 0;
  function show(n){
    i = Math.max(0, Math.min(tot-1, n));
    slides.forEach((s, k)=> s.classList.toggle('active', k===i));
    idxEl.textContent = (i+1);
    bar.style.width = ((i+1)/tot*100).toFixed(1) + '%';
    // Improve accessibility
    slides[i].setAttribute('aria-hidden', 'false');
    slides.forEach((s,k)=>{ if(k!==i) s.setAttribute('aria-hidden','true'); });
  }
  function next(){ show(i+1); }
  function prev(){ show(i-1); }

  document.addEventListener('keydown', (e)=>{
    const key = e.key;
    if(key==='ArrowRight' || key===' ' || key==='PageDown'){ e.preventDefault(); next(); }
    if(key==='ArrowLeft' || key==='PageUp'){ e.preventDefault(); prev(); }
    if(key==='Home'){ e.preventDefault(); show(0); }
    if(key==='End'){ e.preventDefault(); show(tot-1); }
  });

  // Click / tap navigation zones
  document.addEventListener('click', (e)=>{
    const x = e.clientX / window.innerWidth;
    if(x < 0.33) prev();
    else next();
  });

  // Init
  show(0);
})();
</script>
</body>
</html>
